CIK 0001999480 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Alto Neuroscience, Inc.
Sign in to watch- Ticker
- ANRO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 834210124
- Phone
- 773-255-5012
- Business address
- 650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW, CA, 94041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,567,247
- in 1 filing
Net −$3,567,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-10 | Savitz Adam CHIEF MEDICAL OFFICER | Purchase | +2,931 | $13.22 | $39K | 39,851 |
| 2024-07-09 | Savitz Adam CHIEF MEDICAL OFFICER | Purchase | +10,681 | $12.53 | $134K | 35,532 |
| 2024-07-09 | Savitz Adam CHIEF MEDICAL OFFICER | Purchase | +1,388 | $13.15 | $18K | 36,920 |
| 2024-03-28 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER | Purchase | +1,600 | $15.80 | $25K | 22,316 |
| 2024-03-28 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER | Purchase | +4,550 | $16.56 | $75K | 26,866 |
| 2024-02-06 | Alpha Wave Global, LP 10% owner | Purchase | +600,000 | $16.00 | $9.6M | 3,707,757 |
| 2024-02-06 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER | Purchase | +1,563 | $16.00 | $25K | 1,563 |
| 2024-02-06 | Savitz Adam CHIEF MEDICAL OFFICER | Purchase | +17,000 | $16.00 | $272K | 24,851 |
| 2024-02-06 | Etkin Amit PRESIDENT AND CEO | Purchase | +3,125 | $16.00 | $50K | 1,205,465 |
Page 1 of 1 · 9 trades